Search research articles
Contact Us
Filters
Showing results (91-100 of 153) with videos related to
Page
of 16
Sort By:
Surgical Oncology
|
August 6, 2022
The increasing role of abdominal metastesectomy for malignant melanoma in the era of modern therapeutics
Eyal Mor, Shachar Laks, Dan Assaf, et al.
Cancer Immunology Research
|
June 22, 2022
Adenosine-Deaminase-Acting-on-RNA-1 Facilitates T-cell Migration toward Human Melanoma Cells
Naama Margolis, Hanna Moalem, Tomer Meirson, et al.
Molecular Systems Biology
|
April 30, 2009
Predicting and controlling the reactivity of immune cell populations against cancer
Kfir Oved, Eran Eden, Martin Akerman, et al.
American Journal of Therapeutics
|
June 11, 2014
Melanoma early detection and awareness: how countries developing melanoma awareness programs could benefit from melanoma-proficient countries
Alberto Wainstein, Salvador Martin Algarra, Lars Bastholt, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
February 10, 2011
Establishment and large-scale expansion of minimally cultured "young" tumor infiltrating lymphocytes for adoptive transfer therapy
Orit Itzhaki, Einat Hovav, Yaara Ziporen, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
August 2, 2013
A comparative analysis of total serum miRNA profiles identifies novel signature that is highly indicative of metastatic melanoma: a pilot study
Eyal Greenberg, Michal J Besser, Eytan Ben-Ami, et al.
Cancer Immunology Research
|
October 3, 2018
Clinical Significance of Pancreatic Atrophy Induced by Immune-Checkpoint Inhibitors: A Case-Control Study
Yael Eshet, Erez Nissim Baruch, Ronnie Shapira-Frommer, et al.
Oncotarget
|
September 5, 2015
A novel immune resistance mechanism of melanoma cells controlled by the ADAR1 enzyme
Gilli Galore-Haskel, Yael Nemlich, Eyal Greenberg, et al.
British Journal of Cancer
|
September 12, 2018
Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006
Omid Hamid, Caroline Robert, Antoni Ribas, et al.
Cancer Immunology, Immunotherapy : CII
|
July 28, 2009
Systemic dysregulation of CEACAM1 in melanoma patients
Gal Markel, Rona Ortenberg, Rachel Seidman, et al.
Page
of 16
Search research articles
Search
Showing results (91-100 of 153) with videos related to
Sort By:
Page
of 16
Surgical Oncology
|
August 6, 2022
The increasing role of abdominal metastesectomy for malignant melanoma in the era of modern therapeutics
Eyal Mor, Shachar Laks, Dan Assaf, et al.
Cancer Immunology Research
|
June 22, 2022
Adenosine-Deaminase-Acting-on-RNA-1 Facilitates T-cell Migration toward Human Melanoma Cells
Naama Margolis, Hanna Moalem, Tomer Meirson, et al.
Molecular Systems Biology
|
April 30, 2009
Predicting and controlling the reactivity of immune cell populations against cancer
Kfir Oved, Eran Eden, Martin Akerman, et al.
American Journal of Therapeutics
|
June 11, 2014
Melanoma early detection and awareness: how countries developing melanoma awareness programs could benefit from melanoma-proficient countries
Alberto Wainstein, Salvador Martin Algarra, Lars Bastholt, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
February 10, 2011
Establishment and large-scale expansion of minimally cultured "young" tumor infiltrating lymphocytes for adoptive transfer therapy
Orit Itzhaki, Einat Hovav, Yaara Ziporen, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
August 2, 2013
A comparative analysis of total serum miRNA profiles identifies novel signature that is highly indicative of metastatic melanoma: a pilot study
Eyal Greenberg, Michal J Besser, Eytan Ben-Ami, et al.
Cancer Immunology Research
|
October 3, 2018
Clinical Significance of Pancreatic Atrophy Induced by Immune-Checkpoint Inhibitors: A Case-Control Study
Yael Eshet, Erez Nissim Baruch, Ronnie Shapira-Frommer, et al.
Oncotarget
|
September 5, 2015
A novel immune resistance mechanism of melanoma cells controlled by the ADAR1 enzyme
Gilli Galore-Haskel, Yael Nemlich, Eyal Greenberg, et al.
British Journal of Cancer
|
September 12, 2018
Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006
Omid Hamid, Caroline Robert, Antoni Ribas, et al.
Cancer Immunology, Immunotherapy : CII
|
July 28, 2009
Systemic dysregulation of CEACAM1 in melanoma patients
Gal Markel, Rona Ortenberg, Rachel Seidman, et al.
Page
of 16